Science Meets Innovation

TSVascular BV was founded to address a major unmet need in cardiovascular healthcare: vascular wall damage and dysfunction, the root cause of many life-threatening conditions. Using a patented STS formulation, we aim to provide an effective, patient-friendly, long-term solution. Our acid-resistant, controlled-release tablet enables oral delivery of STS—something previously impossible due to its chemical instability in the stomach.